Similar Articles
1431 Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma
1432 Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: A pilot study
1433 Axl glycosylation mediates tumor cell proliferation, invasion and lymphatic metastasis in murine hepatocellular carcinoma
1434 Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma
1435 Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study
1436 High-risk esophageal varices in patients treated with locoregional therapy for hepatocellular carcinoma: Assessment with liver computed tomography
1437 Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma
1438 Prognosis of hepatocellular carcinoma expressing cytokeratin 19: Comparison with other liver cancers
1439 Hyperthermia inhibits hypoxia-induced epithelial-mesenchymal transition in HepG2 hepatocellular carcinoma cells
1440 Hepatocellular carcinoma treated with transarterial chemoembolization: Evaluation with parametric contrast-enhanced ultrasonography
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA